# Diuretics, Hypertension, and Arrhythmias Clinical Trial

> **NCT00000525** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 233 (actual)

## Conditions studied

- Cardiovascular Diseases
- Death, Sudden, Cardiac
- Heart Arrest
- Heart Diseases
- Hypertension

## Interventions

- **DRUG:** hydrochlorothiazide
- **BEHAVIORAL:** diet, potassium supplementation
- **BEHAVIORAL:** diet, magnesium supplementation
- **DRUG:** triamterene
- **DRUG:** chlorthalidone

## Key facts

- **NCT ID:** NCT00000525
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1986-07
- **Primary completion:** 1989-09
- **Final completion:** —
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2013-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000525, "Diuretics, Hypertension, and Arrhythmias Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*